关键信息
-
基因名
tsr
- 应用
-
别名
tsr；Pre-rRNA-processing Protein TSR2 homolog
-
种属
E.coli
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P02942
-
表达区间
211-551aa
-
氨基酸序列
WFGIKASLVAPMNRLIDSIRHIAGGDLVKPIEVDGSNEMGQLAESLRHMQGELMRTVGDVRNGANAIYSGASEIATGNNDLSSRTEQQAASLEETAASMEQLTATVKQNAENARQASHLALSASETAQRGGKVVDNVVQTMRDISTSSQKIADIISVIDGIAFQTNILALNAAVEAARAGEQGRGFAVVAGEVRNLAQRSAQAAREIKSLIEDSVGKVDVGSTLVESAGETMAEIVSAVTRVTDIMGEIASASDEQSRGIDQVGLAVAEMDRVTQQNAALVEESAAAAAALEEQASRLTEAVAVFRIQQQQRETSAVVKTVTPAAPRKMAVADSEENWETF
-
分子量
38.0 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
质检流程
相关产品
背景信息
TSR (Thrombospondin Type 1 Domain) recombinant proteins have garnered significant interest in biomedical research due to their crucial roles in cellular processes such as cell adhesion, migration, and angiogenesis. Originally identified as a component of the extracellular matrix, TSR domains are known for their ability to interact with various cellular receptors and extracellular matrix proteins, thereby influencing cell behavior and signaling pathways. In recent years, researchers have focused on the therapeutic potential of TSR domain-containing proteins in various diseases, including cancer, where they may act as tumor suppressors, and cardiovascular disorders, where they may contribute to the regulation of blood vessel formation. The ability to produce TSR recombinant proteins in sufficient quantities allows for detailed studies on their biochemical properties and interactions, enabling the exploration of their functional applications in drug development and tissue engineering. Furthermore, investigations into the structural characteristics of TSR domains using techniques such as X-ray crystallography and NMR have provided insights into their mechanisms of action, paving the way for the design of targeted therapies that harness their biological activities. As the understanding of TSR proteins continues to evolve, their utilization in clinical settings holds promise for innovative treatments aimed at modulating complex biological processes.
